NUCLEIC ACID VACCINE COMPOSITIONS HAVING A MAMMALIAN CD80/CD86 GENE PROMOTER DRIVING ANTIGEN EXPRESSION - Patent 1240343

(19)

(11)

EP 1 240 343 A2

(12)

(88)	Date of publication A3:
	25.07.2002

(43)	Date of publication:
	18.09.2002 Bulletin 2002/38

(21)	Application number: 00975544.8

(22)	Date of filing: 01.11.2000

(51)	International Patent Classification (IPC)⁷: C12N 15/85, C12N 15/63, C12N 15/28, C12N 15/19, A61K 31/713, C07K 14/705, C07K 14/475, A61K 39/39, A61K 38/19

(86)	International application number:
	PCT/US0030/223

(87)	International publication number:
	WO 0103/2204 (10.05.2001 Gazette 2001/19)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

03.11.1999 US 432983

(71)	Applicant: Powderject Vaccines, Inc.
	Madison, Wisconsin 53711 (US)

(72)	Inventors:
	UMLAUF, Scott Madison, WI 53711 (US) ROBERTS, Lee, K Madison, WI 53711 (US)

(74)	Representative: Woods, Geoffrey Corlett
	J.A. KEMP & CO.Gray's Inn14 South Square London WC1R 5JJ London WC1R 5JJ (GB)

(54)	NUCLEIC ACID VACCINE COMPOSITIONS HAVING A MAMMALIAN CD80/CD86 GENE PROMOTER DRIVING ANTIGEN EXPRESSION